A new study reports mindfulness group therapy has an equally positive effect for people suffering with depression and anxiety disorders as individual cognitive behavioral therapy.
According to researchers, intestinal bacteria can accelerate Alzheimer's development.
A new blood test to detect biomarkers for Alzheimer's disease is set to undergo trials in the Fall. The test will be able to identify traces of amyloid beta in blood samples with a high degree of accuracy.
Researchers have developed a new model of early embryonic brain development. The model, called MiSTR, allows researchers to create tissue that contains different brain regions and place them next to each other. The model produces results similar to embryonic brain development at five weeks post-fertilization.
Researchers report they have discovered where the earliest signs of Alzheimer's may occur in the brain. Initial accumulation of Alzheimer's associated amyloid beta was discovered in an important functional network, the default mode network.
Study reports tau accumulation in the temporal lobe was 75% higher in women than men.
Researchers at Lund University have developed a new imaging method that can help doctors detect and track Alzheimer's disease in people of different ages more effectively.
Amyloid-beta accumulates in nerve cells and spreads, from cell to cell, via nerve fibers. This process occurs prior to the formation of amyloid plaques in the brain.
Neurofilament light protein in plasma may be a noninvasive biomarker for neurodegeneration associated with Alzheimer's disease.